ASAM Home Page
  • bup

    Free webinar: What Raising the Buprenorphine Cap Means for ASAM Members

    ASAM will offer a FREE webinar to provide detailed information regarding the limit raise and any questions you may have. This is a time sensitive opportunity to learn about the most recent developments with the new buprenorphine limit, the qualifications needed for prescribing, what a “qualified practice setting” is, and how ASAM members and other doctors may be affected by this recent development. 

    Read More

  • State of the Art Course

    The State of the Art Course in Addiction Medicine

    October 6 - 8, 2016 - Designed specifically for the physician or other health care professional who seeks an advanced level of knowledge about recent breakthroughs in understanding, preventing, diagnosing and treating addiction and co-occurring medical and psychiatric disorders.

  • Opioid Prescribing Course: Safe Practice, Changing Lives

    Oct. 5, 2016 - FREE for prescribers of ER/LA Opioids and all affected by the prescription of ER/LA Opioids. Includes a special unit addressing ER/LA Opioids and addiction. Attend the live meeting or via LIVE Webinar.

  • The ASAM Buprenorphine Course

    Oct. 5, 2016 - This combined independent online study and face-to-face live education will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid use disorders.

  • News July 13, 2016

    Congress Passes CARA! ASAM applauds passage of historic addiction legislation

    The U.S. Senate voted overwhelmingly to pass the Comprehensive Addiction and Recovery Act (CARA). The Senate vote follows a similar near-unanimous vote in the House of Representatives last week and will send the bill to the President’s desk for his signature. The American Society of Addiction Medicine (ASAM) joins other members of the addiction prevention, treatment and recovery community in celebrating the passage of this important piece of legislation and calls on Congress to fulfill its commitment to fund CARA fully this year.
    Full story
  • News July 6, 2016

    Summary: Major components of the HHS final rule. Effective August 8, 2016.

    On July 6, 2016, the Department of Health and Human Services (HHS) released a final rule to increase access to medication-assisted treatment with buprenorphine products in the office setting by allowing eligible practitioners to request approval to treat up to 275 patients. Read a summary of the final rule.
    Full story

Join the leading professional society in addiction medicine.

Join ASAM today

Our nationwide directory of addiction medicine professionals.

Find a physician

Receive weekly updates from ASAM with the ASAM Weekly.

Sign up now

ASAM Career Center